Intelligence Unit
Special Reports
Special Events
Subscribe/Buy
Sponsored
Departments
- Leadership
- Finance
- Technology
- Physicians
- Community Hospitals
- Health Plans
- Marketing
- Quality
- Nursing
- HR
Follow Us
Ex-Genzyme CEO gives $10M for MGH cancer center
Boston Globe, September 14, 2011
The former chief executive of biotechnology company Genzyme Corp. is donating $10 million to Massachusetts General Hospital to help establish a center to study personalized cancer treatment.The donation announced Tuesday will help the hospital launch the Henri and Belinda Termeer Center for Targeted Therapies. It will focus on developing and testing new generations of molecular-based drugs that attack specific genetic mutations responsible for various cancers.
Most Viewed
Most Emailed
- Urologists 'Outraged' Over PSA Test Challenge
- New Facebook Page Gathers Stories of Medical Harm
- Luxury Hospital Facilities Put Patient Experience First
- Five Hospitals Share Three Secrets to Improve Knee Surgery Outcomes
- Heartland Health Joins Mayo Clinic Network
- Beleaguered Fairview Health CEO to Retire in July
- Health Insurance Exchanges Put Defined Benefits to the Test
- Challenging Physicians to Help Improve the ED
- How Rivals Built an ACO
- For hospitals and insurers, new fervor to cut costs
